# Oral Cladribine B-cell Study

> **NCT06415864** · — · COMPLETED · sponsor: **Queen Mary University of London** · enrollment: 10 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06415864
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-01
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06415864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06415864, "Oral Cladribine B-cell Study". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06415864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*